1. Alley, M. C., Scudiero, D. A., Monks, P. A., Hursey, M., Czerwinski, M. J., Fine, D. L., Abbott, B. J., Mayo, J. G., Shoemaker, R. H., and Boyd, M. R., Feasibility of drugs screening with panels of human tumor cell lines using a microculture tetrazolium assay.Cancer Res., 48, 589–601 (1988).
2. Chen, D. F., Zhang, S. X., Wang, H. K., Zhang, S. Y., Sun, Q. Z., Cosentino, L. M., and Lee, K. H., Novel anti-HIV lancilactone C and related triterpenes fromKadsura lancilimba.J. Nat. Prod., 62, 94–97 (1999).
3. Chen, Y. G., Qin, G. W., and Xie, Y. Y., A novel triterpenoid lactone, schiprolactone A, fromSchisandra propinqua (Wall.) Hook. f. et Thorns.Chin. J. Chem., 19, 304–307 (2001a).
4. Chen, Y. G., Qin, G. W., Cao, L, Leng, Y, and Xie, Y. Y., Triterpenoid acids with cytotoxic effect on rat luteal cells and human decidual cellsin vitro fromSchisandra propinqua.Fitoterapia, 72, 434–436 (2001b).
5. Grever, M. R., Schepartz, S. A., and Chabner, B. A., The national cancer institute: cancer drug discovery and development program.Seminars in Oncology, 19, 622–638 (1992).